Showing 176 Results
New Research Finds Commercial Health Plans' Use of Prescriber Requirements Doubled and Use of Step Therapy Increased by More Than 31% for Specialty Drug Coverage
New research co-authored by NPC examines how health plan policies have become more restrictive over time.
National Pharmaceutical Council Adds Executive Leaders, Names Dr. Jon Campbell as Chief Science Officer
Michael Pratt named Chief Communications Officer as NPC boosts research and engagement capabilities
Innovation Matters: Changing Lives for Cystic Fibrosis Patients
In this video from NPC’s Innovation Matters series, cystic fibrosis patient advocate Katherine Fielding discusses how the invention of modulator therapies has changed her life and how more innovation…
Innovation Matters: Revolutionary Changes for Arthritis Patients
Anna Hyde, vice president of advocacy and access for the Arthritis Foundation, discusses how biopharmaceutical innovation has advanced the health of people living with arthritis.
Innovation Matters: The Evolution of Cancer Therapies
In this video from NPC’s Innovation Matters series, Dr. Peter Emtage describes the evolution of cancer therapies and the importance of ensuring patient access to these medicines.
Innovation Matters: The Unintended Consequences of Drug Pricing Regulation
In NPC’s Innovation Matters video series, hear from patient advocates, researchers, and other stakeholders about the potential unintended consequences for patient health if drug pricing policies harm…
Innovation Matters: Building a Healthier World
In NPC’s new Innovation Matters video series, patient advocates, researchers, and other stakeholders talk about the importance of biopharmaceutical innovation for patient health.
Employers Identify Best Practices for High-Deductible Health Plans in New Research From the National Pharmaceutical Council and Gallagher Research & Insights
Webinar highlights new research and steps employers can take to implement better HDHP designs.
National Pharmaceutical Council Appoints Dr. Sharon Phares as Chief Scientific Officer
NPC announced the appointment of Sharon Phares, PhD, MPH, as Chief Scientific Officer.
Mallinckrodt’s Steven Romano Elected National Pharmaceutical Council Board Chair
NPC announced Steven Romano, MD, Executive Vice President and Chief Scientific Officer, Mallinckrodt Pharmaceuticals, has been elected Chair of NPC’s Board of Directors for 2021-2022.
NPC Commits to Mandating COVID-19 Vaccination
NPC joined a group of 14 health care organizations in and around Washington, D.C., in issuing a joint statement making COVID-19 vaccination a condition of returning to work in their respective…
The Budget Cap Dilemma: Can You Reduce Spending and Preserve Patient Health?
National Pharmaceutical Council (NPC) hosted a virtual panel discussion on state decisions to implement budget caps and the strategies, challenges, and the relevance of these decisions on patient…
National Pharmaceutical Council Appoints John M. O’Brien as President and CEO
Veteran drug pricing and health policy expert John M. O’Brien, Pharm.D., MPH, has been appointed as president and chief executive officer of the National Pharmaceutical Council, effective June 1,…
The American Journal of Managed Care® Adds National Pharmaceutical Council to Strategic Alliance Partnership Program
The American Journal of Managed Care® (AJMC®) and Pharmacy Times® today announced that the National Pharmaceutical Council (NPC) has joined their Strategic Alliance Partnership (SAP) programs.
National Pharmaceutical Council Names Dr. Robert Dubois as Interim President and CEO
As interim president and CEO, Dr. Robert Dubois plans to focus on two priorities: continuing to leverage NPC's ongoing evidence-based research, partnerships and education, and preparing for future…
NPC Announces Departure of President and CEO Dan Leonard
Dan Leonard is leaving as head of the National Pharmaceutical Council, effective Sept. 4.
Webinar: It's Time to Talk About COVID-19 Prices
This 2020 webinar brought together experts to discuss pricing, the pandemic and providing incentives to encourage continued innovation.
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow
Dr. Salama Freed has been named NPC/Duke-Margolis Health Policy Fellow for 2020-22.